Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FCY8L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $71,037
Award facts
- Contract value 100% obligated
- $71,037.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $71,037.17 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors, with a completion date of January 12, 2026. This is a firm fixed-price delivery order with no set-aside designation, awarded on a competitive basis. The contract is a child award under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. This prime IDC serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
Repatha is a prescription medication used for cholesterol management in patients with familial hypercholesterolemia or established cardiovascular disease. The delivery order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a leading pharmaceutical distributor. AmerisourceBergen demonstrates significant capability in federal medical procurement, regularly supplying specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military treatment facilities and the broader federal healthcare system through its extensive contract portfolio with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26FCY8L?
SPE2DR26FCY8L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FCY8L worth?
The government has obligated $71,037 on SPE2DR26FCY8L.
Is contract SPE2DR26FCY8L an order under another contract?
Yes. SPE2DR26FCY8L is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCY8L competed?
The extent of competition for SPE2DR26FCY8L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award